TAG was proud to sign on to this 2/3/25 letter created by HIV Health Care Access Working Group (HHCAWG) of the Federal AIDS Policy Partnership (FAPP). It’s addressed to Congressional leaders and urges Congress to adamantly reject all proposals to enact cuts to Medicaid, a vital source of HIV prevention, treatment, and care.
The new U.S. presidential administration has issued several executive orders, which use pseudo-scientific claims to deny the existence of transgender and non-binary people.
Treatment Action Group’s (TAG) most important fundraising event of the year is the Research in Action Awards, which honor the best and brightest activists, researchers, leaders, and scientists whose work has been integral in ending HIV, tuberculosis (TB), and hepatitis C (HCV).
Treatment Action Group (TAG) elected three new members to its Board of Directors in May 2024. Board President Ivy Kwan Arce said, "TAG is reinvigorating its Board in alignment with our vision, mission, and values.
In response to disheartening news of the proposed $5.3 million cut in HIV/AIDS funding by the Adams administration, we at Treatment Action Group (TAG) express our resolute opposition, in solidarity with our partner organizations that would be harmed by the egregious, unconscionable cuts to HIV services and programs in New York City.
Treatment Action Group (TAG) seeks a dynamic, motivated, and skilled individual to become its Director of Development supporting the organization as it continues to grow.
Follow along with one of our staff members on a typical day, and you'll see the difference you make as a TAG donor and partner.
On May 7 and 21, TAG celebrated Pride season by hosting for an essential webinar that addressed the unique health concerns of the LGBTQ+ community, focusing on engaging LGBTQ patients.
On March 26, 2024, TAG presented this webinar that discusses implementing long-lasting injectable PrEP treatments and the evolving landscape of HIV prevention.
These two policy briefs explore two as yet untapped sources for drug-resistant tuberculosis (DR-TB) research funding within the U.S. Department of Health and Human Services (HHS).